申请人:——
公开号:US20040087593A1
公开(公告)日:2004-05-06
This invention relates to compounds which have generally 5-HT6 receptor affinity and which are represented by Formula I:
1
wherein R
1
, R
2
, R
3
, R
4
, and R
5
are as defined herein; or individual isomers, racemic or non-racemic mixtures of isomers, or pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds, methods for their use as therapeutic agents, and methods of preparation thereof.
本发明涉及一种通常具有5-HT6受体亲和力的化合物,其由公式I表示:其中R1、R2、R3、R4和R5如本文所定义;或其单一异构体、外消旋或非外消旋异构体混合物,或其药学上可接受的盐或溶剂化物。本发明还涉及包含这些化合物的制药组合物,它们作为治疗剂的使用方法,以及它们的制备方法。